|4Jan 14, 6:57 PM ET

Nardo Christopher J. 4

4 · Dermata Therapeutics, Inc. · Filed Jan 14, 2025

Insider Transaction Report

Form 4
Period: 2025-01-13
Nardo Christopher J.
Senior VP, CDO
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-13+20,00020,000 total
    Exercise: $1.38From: 2025-01-14Exp: 2035-01-12Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT